Recently, Jablonska and colleagues [42] have demonstrated that endogenous IFNβ inhibits angiogenesis, by inhibiting pro-angiogenic genes within tumour associated neutrophils, in a transplantable mouse tumour model. This evidence concerns the gene IFNB1 and neoplasm.